Financial results - JENSEN PHARMA SRL

Financial Summary - Jensen Pharma Srl
Unique identification code: 33391932
Registration number: J2014008459401
Nace: 4646
Sales - Ron
1.233.661
Net Profit - Ron
158.354
Employees
7
Open Account
Company Jensen Pharma Srl with Fiscal Code 33391932 recorded a turnover of 2024 of 1.233.661, with a net profit of 158.354 and having an average number of employees of 7. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Jensen Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 9.537 39.739 63.878 163.994 219.729 390.047 551.197 773.565 979.588 1.233.661
Total Income - EUR 9.813 40.691 63.910 164.067 219.806 390.830 551.342 777.408 987.671 1.237.000
Total Expenses - EUR 9.893 38.822 57.267 122.913 188.072 320.070 429.263 641.354 772.543 1.053.121
Gross Profit/Loss - EUR -80 1.869 6.643 41.154 31.734 70.761 122.079 136.054 215.128 183.879
Net Profit/Loss - EUR -366 649 5.302 39.513 29.537 67.846 118.199 131.020 192.140 158.354
Employees 0 0 1 2 3 4 5 7 7 7
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 26.6%, from 979.588 euro in the year 2023, to 1.233.661 euro in 2024. The Net Profit decreased by -32.712 euro, from 192.140 euro in 2023, to 158.354 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Jensen Pharma Srl

Rating financiar

Financial Rating -
JENSEN PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Jensen Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Jensen Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Jensen Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Jensen Pharma Srl - CUI 33391932

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 90 33 5.958 19.314 13.224 7.339 3.711 24.845 77.479 91.956
Current Assets 14.330 19.451 33.896 89.370 99.705 214.226 316.215 312.385 569.667 625.266
Inventories 7.321 7.587 16.243 10.867 19.537 49.362 55.050 114.646 211.300 228.132
Receivables 1.736 5.303 11.283 9.166 27.807 83.447 65.028 116.968 182.729 247.806
Cash 5.273 6.560 6.370 69.337 52.361 81.417 196.137 80.771 175.638 149.327
Shareholders Funds -2.285 -1.613 3.716 43.161 45.603 106.795 217.127 261.188 417.443 468.141
Social Capital 45 45 44 43 42 41 2.022 2.028 2.022 2.010
Debts 16.705 21.097 36.771 66.637 67.868 115.090 102.867 77.667 232.371 252.097
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 625.266 euro in 2024 which includes Inventories of 228.132 euro, Receivables of 247.806 euro and cash availability of 149.327 euro.
The company's Equity was valued at 468.141 euro, while total Liabilities amounted to 252.097 euro. Equity increased by 53.030 euro, from 417.443 euro in 2023, to 468.141 in 2024.

Risk Reports Prices

Reviews - Jensen Pharma Srl

Comments - Jensen Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.